The global AL amyloidosis therapeutics market is poised for significant expansion in the forthcoming years, with estimations projecting a value of USD 2.25 billion by 2023, surging to a remarkable USD 4.56 billion by 2033, marking a robust Compound Annual Growth Rate (CAGR) of 7.3%. These insights emerge from a comprehensive report by Future Market …